Clinical Trial Update: S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML [Phase 3]

View source ↗

Summary

Phase 3 trial S0106 in de novo acute myeloid leukemia comparing cytarabine and daunorubicin with or without gemtuzumab ozogamicin, followed by high-dose cytarab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Gemtuzumab ozogamicin (Mylotarg) (gemtuzumab ozogamicin)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2012-08-27